Primary antiphospholipid syndrome: therapeutic management during pregnancy

封面


如何引用文章

全文:

详细

Objective: To test hypothesis that plasmapheresis could be effective in complex therapy of primary antiphospholipid syndrome in women with recurrent pregnancy losses during pregnancy.

全文:

Objective: To test hypothesis that plasmapheresis could be effective in complex therapy of primary anti phospholipid syndrome in women with recurrent pregnancy losses during pregnancy.

Methods: We studied 156 pregnant women with primary anti phospholipid syndrome and recurrent pregnancy losses. Tests to detect LA, including the activated partial thromboplastin time (APTT), the kaolin clotting time, were performed.

Results: Positive results were found in all pregnant women with associated clinical complications. In the first group (81 patients) we used immunosuppressive drugs in low doses - prednisone (5-10 mg/day) or methipred (4-8 mg/day) combined with low-dose aspirin (100 mg/day) and, if necessary - anticoagulant treatment subcutaneous heparin. In the second group (75 cases) we used corticoids, aspirin and plasmapheresis 3 times during pregnancy. 8/81 (9,8%) pregnancies in the first group and 5/75 (6,6%) in the second group terminated as preterm labor on 32-34 weeks of gestation. After 3 session of plasmapheresis it was noted absence of LA in venous blood in 65/75 (86,7%) of patients. Normalization of haemostasiogramm (decrease of thrombodynamic potential index), plateletys aggregation, disappearance of DIC markers was noted in 70/75 (93,3%) of patients. Successful pregnancies have been obtained in 67/75 (89,3%) cases.

Conclusion: Plasmapheresis may be effective in complex therapy of primary anti phospholipid syndrome in patients with recurrent pregnancy losses.

×

作者简介

A. Agadjanova

Research Center of Obstetrics, Gynecology and Perinatology, Russian Academy of Medical Sciences

编辑信件的主要联系方式.
Email: info@eco-vector.com
俄罗斯联邦, Moscow

V. Sidelnikova

Research Center of Obstetrics, Gynecology and Perinatology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
俄罗斯联邦, Moscow

A. Abubakirova

Research Center of Obstetrics, Gynecology and Perinatology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
俄罗斯联邦, Moscow

参考

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eсо-Vector, 1999



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.